TY - JOUR
T1 - Allergen immunotherapy for allergic rhinoconjunctivitis
T2 - protocol for a systematic review
AU - Dhami, Sangeeta
AU - Nurmatov, Ulugbek
AU - Roberts, Graham
AU - Pfaar, Oliver
AU - Muraro, Antonella
AU - Ansotegui, Ignacio J
AU - Calderon, Moises
AU - Cingi, Cemal
AU - Demoly, Pascal
AU - Durham, Stephen
AU - van Wijk, Ronald Gerth
AU - Halken, Susanne
AU - Hamelmann, Eckard
AU - Hellings, Peter
AU - Jacobsen, Lars
AU - Knol, Edward
AU - Linnemann, Desiree Larenas
AU - Lin, Sandra
AU - Maggina, Vivian
AU - Oude-Elberink, Hanneke
AU - Pajno, Giovanni
AU - Panwankar, Ruby
AU - Pastorello, Elideanna
AU - Pitsios, Constantinos
AU - Rotiroti, Giuseppina
AU - Timmermans, Frans
AU - Tsilochristou, Olympia
AU - Varga, Eva-Maria
AU - Wilkinson, Jamie
AU - Williams, Andrew
AU - Worm, Margitta
AU - Zhang, Luo
AU - Sheikh, Aziz
PY - 2016/3/22
Y1 - 2016/3/22
N2 - BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for the Management of Allergic Rhinoconjunctivitis. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in the management of allergic rhinoconjunctivitis.METHODS: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised.CONCLUSION: The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.
AB - BACKGROUND: The European Academy of Allergy and Clinical Immunology (EAACI) is in the process of developing the EAACI Guidelines for Allergen Immunotherapy (AIT) for the Management of Allergic Rhinoconjunctivitis. We seek to critically assess the effectiveness, cost-effectiveness and safety of AIT in the management of allergic rhinoconjunctivitis.METHODS: We will undertake a systematic review, which will involve searching international biomedical databases for published, in progress and unpublished evidence. Studies will be independently screened against pre-defined eligibility criteria and critically appraised using established instruments. Data will be descriptively and, if possible and appropriate, quantitatively synthesised.CONCLUSION: The findings from this review will be used to inform the development of recommendations for EAACI's Guidelines on AIT.
U2 - 10.1186/s13601-016-0099-6
DO - 10.1186/s13601-016-0099-6
M3 - Article
C2 - 27006751
SN - 2045-7022
VL - 6
SP - 12
JO - Clinical and translational allergy
JF - Clinical and translational allergy
IS - 12
ER -